Intra-Cellular Therapies, Inc.: key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024): $680.9M
Net Income/Loss (FY2024): -$74.7M
Total Assets (FY2024): $1.4B
Total Equity (FY2024): $1.1B
Cash Flows from Operating Activities (FY2024): -$73.2M

Source: Intra-Cellular Therapies, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Intra-Cellular Therapies, Inc. Financials | Hub-Equity